See more : Machvision Inc. (3563.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Porton Pharma Solutions Ltd. (300363.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Porton Pharma Solutions Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Murata Manufacturing Co., Ltd. (MRAAF) Income Statement Analysis – Financial Results
- Safe-T Group Ltd. (SFET) Income Statement Analysis – Financial Results
- River Eletec Corporation (6666.T) Income Statement Analysis – Financial Results
- Fortescue Metals Group Limited (FSUGY) Income Statement Analysis – Financial Results
- Shanying International Holdings Co.,Ltd (600567.SS) Income Statement Analysis – Financial Results
Porton Pharma Solutions Ltd. (300363.SZ)
About Porton Pharma Solutions Ltd.
Porton Pharma Solutions Ltd. manufactures and supplies small molecule active pharmaceutical ingredients and drug intermediates, dosage forms, and biologics to the pharmaceutical companies. The company was formerly known as Porton Fine Chemicals Ltd. and changed its name to Porton Pharma Solutions Ltd. in January 2018. Porton Pharma Solutions Ltd. was founded in 2005 and is headquartered in Chongqing, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.67B | 7.03B | 3.11B | 2.07B | 1.55B | 1.18B | 1.18B | 1.33B | 1.02B | 987.26M | 734.36M | 689.88M | 552.57M | 455.83M | 288.54M |
| Cost of Revenue | 2.23B | 3.38B | 1.82B | 1.21B | 964.28M | 788.37M | 749.00M | 800.44M | 688.72M | 624.75M | 447.76M | 449.87M | 366.73M | 318.30M | 183.98M |
| Gross Profit | 1.44B | 3.66B | 1.28B | 863.53M | 587.02M | 396.49M | 435.09M | 526.20M | 332.49M | 362.50M | 286.60M | 240.01M | 185.83M | 137.53M | 104.56M |
| Gross Profit Ratio | 39.19% | 51.96% | 41.36% | 41.68% | 37.84% | 33.46% | 36.74% | 39.66% | 32.56% | 36.72% | 39.03% | 34.79% | 33.63% | 30.17% | 36.24% |
| Research & Development | 452.23M | 519.51M | 263.82M | 157.84M | 122.55M | 76.20M | 75.33M | 0.00 | 50.34M | 42.55M | 40.99M | 33.39M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 192.47M | 145.44M | 71.01M | 47.47M | 49.98M | 45.78M | 48.64M | 60.30M | 43.97M | 51.00M | 40.59M | 29.37M | 27.16M | 21.80M | 49.17M |
| Selling & Marketing | 46.64M | 203.29M | 97.02M | 76.71M | 45.16M | 29.47M | 20.64M | 16.78M | 13.24M | 15.34M | 12.64M | 11.89M | 11.81M | 6.27M | 3.13M |
| SG&A | 239.11M | 348.74M | 168.02M | 124.18M | 95.14M | 75.25M | 69.28M | 77.08M | 57.22M | 66.34M | 53.23M | 41.26M | 38.97M | 28.08M | 52.30M |
| Other Expenses | 476.88M | 500.55M | 214.84M | 171.48M | 145.73M | -21.10M | 171.53K | 9.78M | 10.61M | 10.27M | 8.55M | 3.01M | 4.49M | 2.81M | 1.49M |
| Operating Expenses | 1.17B | 1.37B | 646.69M | 453.50M | 363.42M | 264.18M | 245.96M | 262.69M | 183.16M | 185.97M | 152.16M | 120.14M | 100.34M | 69.12M | 53.95M |
| Cost & Expenses | 3.40B | 4.75B | 2.47B | 1.66B | 1.33B | 1.05B | 994.96M | 1.06B | 871.88M | 810.72M | 599.92M | 570.00M | 467.07M | 387.42M | 237.93M |
| Interest Income | 57.88M | 22.83M | 14.31M | 22.39M | 33.37M | 24.44M | 1.68M | 475.91K | 712.42K | 786.91K | 481.57K | 396.38K | 365.07K | 292.15K | -0.92 |
| Interest Expense | 46.68M | 27.73M | 21.70M | 24.39M | 42.77M | 62.79M | 48.95M | 38.87M | 28.03M | 14.52M | 6.44M | 9.03M | 4.77M | 3.97M | 7.02M |
| Depreciation & Amortization | 349.11M | 266.38M | 196.29M | 131.50M | 116.96M | 123.49M | 114.72M | 79.40M | 55.98M | 29.51M | 17.75M | 14.64M | 12.62M | 10.72M | 10.23M |
| EBITDA | 639.82M | 2.53B | 762.74M | 520.93M | 354.47M | 320.30M | 279.88M | 323.60M | 215.77M | 191.87M | 144.68M | 123.97M | 96.44M | 76.30M | 60.84M |
| EBITDA Ratio | 17.45% | 36.71% | 26.54% | 26.29% | 24.67% | 26.14% | 24.29% | 27.65% | 21.92% | 22.05% | 21.01% | 19.50% | 18.42% | 17.71% | 20.38% |
| Operating Income | 268.91M | 2.27B | 565.60M | 352.24M | 265.80M | 153.96M | 114.56M | 207.59M | 129.07M | 142.71M | 115.89M | 99.84M | 74.73M | 59.04M | 45.62M |
| Operating Income Ratio | 7.33% | 32.20% | 18.21% | 17.00% | 17.13% | 12.99% | 9.68% | 15.65% | 12.64% | 14.45% | 15.78% | 14.47% | 13.52% | 12.95% | 15.81% |
| Total Other Income/Expenses | -22.35M | -19.27M | -16.77M | 11.51M | -1.27M | -21.10M | 171.54K | -2.26M | 2.68M | 5.14M | 4.60M | -11.60M | 4.32M | 2.57M | 1.49M |
| Income Before Tax | 246.56M | 2.25B | 548.83M | 363.74M | 193.42M | 132.87M | 114.74M | 205.33M | 131.76M | 147.85M | 120.49M | 100.31M | 79.05M | 61.61M | 47.11M |
| Income Before Tax Ratio | 6.72% | 31.92% | 17.67% | 17.56% | 12.47% | 11.21% | 9.69% | 15.48% | 12.90% | 14.98% | 16.41% | 14.54% | 14.31% | 13.52% | 16.33% |
| Income Tax Expense | 71.05M | 309.38M | 73.24M | 40.55M | 13.80M | 21.42M | 20.24M | 42.88M | 26.12M | 25.27M | 19.71M | 19.21M | 17.15M | 14.46M | 13.40M |
| Net Income | 266.86M | 2.01B | 523.92M | 324.42M | 185.55M | 124.49M | 107.45M | 171.19M | 110.39M | 125.49M | 100.20M | 80.27M | 62.40M | 43.05M | 30.23M |
| Net Income Ratio | 7.28% | 28.51% | 16.87% | 15.66% | 11.96% | 10.51% | 9.07% | 12.90% | 10.81% | 12.71% | 13.64% | 11.64% | 11.29% | 9.44% | 10.48% |
| EPS | 0.49 | 3.70 | 0.98 | 0.61 | 0.35 | 0.26 | 0.25 | 0.41 | 0.27 | 0.32 | 0.28 | 0.22 | 0.17 | 0.14 | 0.11 |
| EPS Diluted | 0.49 | 3.69 | 0.98 | 0.61 | 0.35 | 0.26 | 0.25 | 0.40 | 0.27 | 0.32 | 0.28 | 0.22 | 0.17 | 0.14 | 0.11 |
| Weighted Avg Shares Out | 544.61M | 542.01M | 535.98M | 534.32M | 534.32M | 478.82M | 422.75M | 417.54M | 408.87M | 392.14M | 361.30M | 362.69M | 359.97M | 298.96M | 263.67M |
| Weighted Avg Shares Out (Dil) | 544.61M | 543.48M | 535.98M | 534.32M | 534.32M | 478.82M | 429.80M | 427.97M | 408.87M | 392.14M | 361.30M | 362.69M | 359.97M | 298.96M | 263.67M |
No news found for: 300363.SZ
Source: https://incomestatements.info
Category: Stock Reports